Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Other financing activities: 2020-2025

Historic Other financing activities for Insight Molecular Diagnostics (IMDX) over the last 1 years, with Mar 2025 value amounting to $487,000.

  • Insight Molecular Diagnostics' Other financing activities was N/A to $487,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $1.4 million for FY2024, which is 221.78% up from last year.
  • As of Q1 2025, Insight Molecular Diagnostics' Other financing activities stood at $487,000, which was down 41.75% from $836,000 recorded in Q4 2024.
  • Over the past 5 years, Insight Molecular Diagnostics' Other financing activities peaked at $2.7 million during Q1 2021, and registered a low of -$1,000 during Q4 2021.
  • In the last 2 years, Insight Molecular Diagnostics' Other financing activities had a median value of $538,000 in 2024 and averaged $620,333.
  • Data for Insight Molecular Diagnostics' Other financing activities shows a peak YoY surged of 267,500.00% (in 2021) over the last 5 years.
  • Over the past 3 years, Insight Molecular Diagnostics' Other financing activities (Quarterly) stood at -$1,000 in 2021, then followed by $836,000 in 2024, then followed by $487,000 in 2025.
  • Its Other financing activities stands at $487,000 for Q1 2025, versus $836,000 for Q4 2024 and $538,000 for Q2 2024.